Analysis of primary and acquired resistance to cetuximab from multiomic data in the New EPOC trial. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1200/jco.2023.41.16_suppl.3577
Publication URI: http://dx.doi.org/10.1200/jco.2023.41.16_suppl.3577
Type: Journal Article/Review
Parent Publication: Journal of Clinical Oncology
Issue: 16_suppl